News & Insights2021-01-06T16:17:56-05:00

News & Insights

Impact, observations, and insights to advance translational intelligence

All
Thought Leadership
COVID-19 Data Initiative
Press Releases
Conferences & Events

Centralizing PK, Clinical, and Exploratory Data to Streamline Biomarker-Centric Trial Operations

Conferences & Events, Thought Leadership|

December 10th, 2020 — Biomarker-guided trials frequently have an international footprint of sites to reach targeted patient populations and involve a complex network of specialty labs. Join us for our upcoming webinar, where QuartzBio’s Tobi Guennel will discuss how his team is breaking down data siloes to create actionable insights into availability and quality of samples and data. These insights allow clinical and translational teams to streamline trial operations and enable early course correction.

(more…)

Precision Medicine Group Secures Major Investment from Blackstone

Press Releases|

New York, NY & Bethesda, MD — November 20, 2020 — Precision Medicine Group (PMG) and Blackstone (NYSE: BX) today announced that PMG, a leading next-generation provider of drug development and commercialization services, has completed a major investment and recapitalization led by funds managed by Blackstone (“Blackstone”). The investment includes significant participation from Precision’s co-founders, Ethan Leder and Mark Clein, as well as current shareholders Berkshire Partners, TPG Growth, Oak HC/FT, and Vida Ventures.

(more…)

Enabling Translational Intelligence to Rapidly Surface On-study Operational and Scientific Insights

Thought Leadership|

November 12th, 2020 — In this article, QuartzBio Managing Director Scott Marshall discusses critical steps to integrating clinical, PK, and exploratory data on-study to advance operational and translational insights (without all the manual effort that has become all too common). With our experience working across dozens of clients and hundreds of studies, we’ve identified four key components necessary to efficiently centralize.

(more…)

Reverse causal inferencing on molecular data from lung adenocarcinoma patients reveals a stem cell–like molecular subtype associated with pack-year history

Thought Leadership|

November 9th, 2020 — Advances in high throughput measurement technologies (omics data) have made it possible, and increasingly affordable, to generate high complexity, high volume data for oncology research. QuartzBio’s Renee Deehan poster, “Reverse Causal Inferencing on Lung Adenocarcinoma Patients Reveals a Stem Cell–Like Molecular Subtype Associated with Pack-Year History,” is an insightful look into an exciting area of opportunity.

View the poster

(more…)

A Computational Approach to Modeling COVID-19

Thought Leadership|

October 1st, 2020 — In the months since March 2020, the biotech community has rallied to identify how our unique perspectives and skills can help with the COVID-19 pandemic. The computational biologists at QuartzBio are no different. QuartzBio’s Renee Deehan discusses how using existing published data to build a disease model can answer questions and assist researchers in the fight against COVID-19. Read the article today.

(more…)

Load More Posts